Evaluate ACRS stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ACRS? | Glauxie AI

Q: What are the risks of investing in ACRS?

Aclaris Therapeutics, Inc. (ACRS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Neal S. Walker. Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments:... Employees: 73.

Q: How much debt does ACRS have?

Review ACRS total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ACRS a good long-term investment?

Evaluate ACRS as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ACRS?

🦉

Aclaris Therapeutics, Inc. (ACRS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEONeal S. Walker

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and...

Key Executives

Name	Title
Ajay Aggarwal	Senior Vice President of Clinical Development
Hugh Davis	President, Chief Operating Officer & Director
James Loerop	Chief Business Officer
Jesse W. Hall	Chief Medical Officer
Jon Jacobsen	Senior Vice President of Chemistry
Kevin Balthaser	Chief Financial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ACRS Profile Financials

Is ACRS stock safe? How much debt does ACRS have? Is ACRS a good long-term investment?